Frazier Life Sciences Management, L.P. Portfolio Holdings

Frazier Life Sciences Management, L.P.

  • $1.86 Billion
  • Q3 2024

Frazier Life Sciences Management, L.P. has filed its 13F form on November 15, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.86 Billion distributed in 53 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Mirum Pharmaceuticals, Inc. with a value of $256M, Phathom Pharmaceuticals, Inc. with a value of $183M, Krystal Biotech, Inc. with a value of $180M, Rhythm Pharmaceuticals, Inc. with a value of $127M, and Vaxcyte, Inc. with a value of $100M.

Examining the 13F form we can see an increase of $161M in the current position value, from $1.7B to 1.86B.

Frazier Life Sciences Management, L.P. is based out at Menlo Park, CA

Below you can find more details about Frazier Life Sciences Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.86 Billion
Healthcare: $1.86 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 53
  • Current Value $1.86 Billion
  • Prior Value $1.7 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 15, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 8 stocks
  • Additional Purchases 13 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email